ID   GLCTK_HUMAN             Reviewed;         523 AA.
AC   Q8IVS8; Q0P630; Q2EZ43; Q6Y2K6; Q7Z6G5; Q86YR8; Q8TED2; Q8WTY2;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   18-JUN-2025, entry version 165.
DE   RecName: Full=Glycerate kinase;
DE            EC=2.7.1.31 {ECO:0000269|PubMed:16753811, ECO:0000269|PubMed:20949620};
DE   AltName: Full=HBeAg-binding protein 4;
GN   Name=GLYCTK; Synonyms=HBEBP4; ORFNames=LP5910;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR
RP   LOCATION(ISOFORMS 1 AND 2), CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=16753811; DOI=10.1080/10425170500476665;
RA   Guo J.-H., Hexige S., Chen L., Zhou G.-J., Wang X., Jiang J.-M.,
RA   Kong Y.-H., Ji G.-Q., Wu C.-Q., Zhao S.-Y., Yu L.;
RT   "Isolation and characterization of the human D-glyceric acidemia related
RT   glycerate kinase gene GLYCTK1 and its alternatively splicing variant
RT   GLYCTK2.";
RL   DNA Seq. 17:1-7(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Lung;
RA   Guo J.H.;
RT   "Cloning of HCG9886S gene and identification of a novel domain.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 6).
RA   Zhang J.-K., Cheng J., Lan X.-Y., Guo J., Zhang L.-Y.;
RT   "Screening and cloning of HBeAg binding protein 4.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   KINETIC PARAMETERS, CATALYTIC ACTIVITY, VARIANT D-GA CYS-493, AND
RP   CHARACTERIZATION OF VARIANT D-GA CYS-493.
RX   PubMed=20949620; DOI=10.1002/humu.21375;
RA   Sass J.O., Fischer K., Wang R., Christensen E., Scholl-Burgi S., Chang R.,
RA   Kapelari K., Walter M.;
RT   "D-glyceric aciduria is caused by genetic deficiency of D-glycerate kinase
RT   (GLYCTK).";
RL   Hum. Mutat. 31:1280-1285(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-glycerate + ATP = (2R)-3-phosphoglycerate + ADP + H(+);
CC         Xref=Rhea:RHEA:23516, ChEBI:CHEBI:15378, ChEBI:CHEBI:16659,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58272, ChEBI:CHEBI:456216;
CC         EC=2.7.1.31; Evidence={ECO:0000269|PubMed:16753811,
CC         ECO:0000269|PubMed:20949620};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.1 mM for D-glycerate {ECO:0000269|PubMed:20949620};
CC   -!- INTERACTION:
CC       Q8IVS8; Q5BKX5-3: ACTMAP; NbExp=3; IntAct=EBI-748515, EBI-11976299;
CC       Q8IVS8; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-748515, EBI-10173507;
CC       Q8IVS8; Q8N9V6-2: ANKRD53; NbExp=3; IntAct=EBI-748515, EBI-13345447;
CC       Q8IVS8; Q96C12: ARMC5; NbExp=3; IntAct=EBI-748515, EBI-6425121;
CC       Q8IVS8; Q9Y6H3: ATP23; NbExp=3; IntAct=EBI-748515, EBI-12811889;
CC       Q8IVS8; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-748515, EBI-739580;
CC       Q8IVS8; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-748515, EBI-739624;
CC       Q8IVS8; Q86UW9: DTX2; NbExp=6; IntAct=EBI-748515, EBI-740376;
CC       Q8IVS8; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-748515, EBI-2349927;
CC       Q8IVS8; Q9Y5P6: GMPPB; NbExp=5; IntAct=EBI-748515, EBI-750945;
CC       Q8IVS8; Q08379: GOLGA2; NbExp=6; IntAct=EBI-748515, EBI-618309;
CC       Q8IVS8; Q8IYA8: IHO1; NbExp=3; IntAct=EBI-748515, EBI-8638439;
CC       Q8IVS8; Q53G59: KLHL12; NbExp=3; IntAct=EBI-748515, EBI-740929;
CC       Q8IVS8; P13646: KRT13; NbExp=3; IntAct=EBI-748515, EBI-1223876;
CC       Q8IVS8; P19012: KRT15; NbExp=3; IntAct=EBI-748515, EBI-739566;
CC       Q8IVS8; P08727: KRT19; NbExp=3; IntAct=EBI-748515, EBI-742756;
CC       Q8IVS8; O76011: KRT34; NbExp=3; IntAct=EBI-748515, EBI-1047093;
CC       Q8IVS8; O95678: KRT75; NbExp=3; IntAct=EBI-748515, EBI-2949715;
CC       Q8IVS8; Q3LI72: KRTAP19-5; NbExp=3; IntAct=EBI-748515, EBI-1048945;
CC       Q8IVS8; Q3LI66: KRTAP6-2; NbExp=5; IntAct=EBI-748515, EBI-11962084;
CC       Q8IVS8; Q3LI67: KRTAP6-3; NbExp=3; IntAct=EBI-748515, EBI-22311199;
CC       Q8IVS8; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-748515, EBI-741037;
CC       Q8IVS8; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-748515, EBI-716006;
CC       Q8IVS8; A6NJ78-4: METTL15; NbExp=3; IntAct=EBI-748515, EBI-10174029;
CC       Q8IVS8; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-748515, EBI-8487781;
CC       Q8IVS8; Q9NYP9: MIS18A; NbExp=4; IntAct=EBI-748515, EBI-1104552;
CC       Q8IVS8; Q6PF18: MORN3; NbExp=3; IntAct=EBI-748515, EBI-9675802;
CC       Q8IVS8; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-748515, EBI-10271199;
CC       Q8IVS8; A8MTQ0: NOTO; NbExp=3; IntAct=EBI-748515, EBI-17490746;
CC       Q8IVS8; P49902: NT5C2; NbExp=3; IntAct=EBI-748515, EBI-742084;
CC       Q8IVS8; Q99471: PFDN5; NbExp=3; IntAct=EBI-748515, EBI-357275;
CC       Q8IVS8; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-748515, EBI-79165;
CC       Q8IVS8; Q9UPG8: PLAGL2; NbExp=3; IntAct=EBI-748515, EBI-2876622;
CC       Q8IVS8; P01189: POMC; NbExp=3; IntAct=EBI-748515, EBI-12219503;
CC       Q8IVS8; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-748515, EBI-3957793;
CC       Q8IVS8; Q08623: PUDP; NbExp=3; IntAct=EBI-748515, EBI-12807240;
CC       Q8IVS8; Q9BYM8: RBCK1; NbExp=3; IntAct=EBI-748515, EBI-2340624;
CC       Q8IVS8; Q93062: RBPMS; NbExp=3; IntAct=EBI-748515, EBI-740322;
CC       Q8IVS8; Q04864: REL; NbExp=3; IntAct=EBI-748515, EBI-307352;
CC       Q8IVS8; Q04864-2: REL; NbExp=3; IntAct=EBI-748515, EBI-10829018;
CC       Q8IVS8; Q8IYX7: SAXO1; NbExp=3; IntAct=EBI-748515, EBI-3957636;
CC       Q8IVS8; Q9UHV2: SERTAD1; NbExp=3; IntAct=EBI-748515, EBI-748601;
CC       Q8IVS8; Q53HV7-2: SMUG1; NbExp=3; IntAct=EBI-748515, EBI-12275818;
CC       Q8IVS8; Q96H20: SNF8; NbExp=5; IntAct=EBI-748515, EBI-747719;
CC       Q8IVS8; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-748515, EBI-11959123;
CC       Q8IVS8; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-748515, EBI-5235340;
CC       Q8IVS8; P14373: TRIM27; NbExp=3; IntAct=EBI-748515, EBI-719493;
CC       Q8IVS8; Q8IWZ5: TRIM42; NbExp=3; IntAct=EBI-748515, EBI-5235829;
CC       Q8IVS8; Q15645: TRIP13; NbExp=9; IntAct=EBI-748515, EBI-358993;
CC       Q8IVS8; Q9UGJ1: TUBGCP4; NbExp=3; IntAct=EBI-748515, EBI-1052544;
CC       Q8IVS8; Q6NVU6: UFSP1; NbExp=3; IntAct=EBI-748515, EBI-12068150;
CC       Q8IVS8; Q8TF47: ZFP90; NbExp=3; IntAct=EBI-748515, EBI-11419867;
CC       Q8IVS8; O60844: ZG16; NbExp=3; IntAct=EBI-748515, EBI-746479;
CC       Q8IVS8; Q9NZV7: ZIM2; NbExp=3; IntAct=EBI-748515, EBI-11962760;
CC       Q8IVS8; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-748515, EBI-4395669;
CC       Q8IVS8; P0C7X2: ZNF688; NbExp=3; IntAct=EBI-748515, EBI-4395732;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm
CC       {ECO:0000269|PubMed:16753811}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm. Mitochondrion
CC       {ECO:0000269|PubMed:16753811}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=Glycerate kinase 1 {ECO:0000303|PubMed:16753811},
CC       GLYCTK1 {ECO:0000303|PubMed:16753811};
CC         IsoId=Q8IVS8-1; Sequence=Displayed;
CC       Name=2; Synonyms=Glycerate kinase 2 {ECO:0000303|PubMed:16753811},
CC       GLYCTK2 {ECO:0000303|PubMed:16753811};
CC         IsoId=Q8IVS8-2; Sequence=VSP_025360, VSP_025362;
CC       Name=3;
CC         IsoId=Q8IVS8-3; Sequence=VSP_025358;
CC       Name=4;
CC         IsoId=Q8IVS8-4; Sequence=VSP_025363, VSP_025365;
CC       Name=5;
CC         IsoId=Q8IVS8-5; Sequence=VSP_025357, VSP_025364, VSP_025365;
CC       Name=6;
CC         IsoId=Q8IVS8-6; Sequence=VSP_025356;
CC       Name=7;
CC         IsoId=Q8IVS8-7; Sequence=VSP_025359, VSP_025361;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:16753811}.
CC   -!- DISEASE: D-glyceric aciduria (D-GA) [MIM:220120]: A rare metabolic
CC       disease characterized by chronic metabolic acidosis and a highly
CC       variable clinical phenotype. Clinical features range from an
CC       encephalopathic presentation with seizures, microcephaly, severe
CC       intellectual disability and early death, to milder manifestations with
CC       only speech delay or even normal development.
CC       {ECO:0000269|PubMed:20949620}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycerate kinase type-2 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36862.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY295075; AAP51132.1; -; mRNA.
DR   EMBL; AF448855; AAP41923.1; -; mRNA.
DR   EMBL; AY172690; AAO17719.1; -; mRNA.
DR   EMBL; AY189286; AAO86730.1; -; mRNA.
DR   EMBL; AK074215; BAB85018.1; -; mRNA.
DR   EMBL; AY134474; AAM95456.1; -; mRNA.
DR   EMBL; DQ352863; ABD22985.1; -; mRNA.
DR   EMBL; BC021896; AAH21896.1; -; mRNA.
DR   EMBL; BC036862; AAH36862.1; ALT_FRAME; mRNA.
DR   EMBL; BC042151; AAH42151.1; -; mRNA.
DR   CCDS; CCDS2852.1; -. [Q8IVS8-1]
DR   CCDS; CCDS46841.1; -. [Q8IVS8-2]
DR   RefSeq; NP_001138423.1; NM_001144951.2. [Q8IVS8-2]
DR   RefSeq; NP_660305.2; NM_145262.3. [Q8IVS8-1]
DR   RefSeq; XP_024309119.1; XM_024453351.2. [Q8IVS8-1]
DR   RefSeq; XP_024309120.1; XM_024453352.2. [Q8IVS8-2]
DR   RefSeq; XP_047303421.1; XM_047447465.1. [Q8IVS8-4]
DR   RefSeq; XP_047303422.1; XM_047447466.1. [Q8IVS8-4]
DR   RefSeq; XP_054201255.1; XM_054345280.1. [Q8IVS8-1]
DR   RefSeq; XP_054201256.1; XM_054345281.1. [Q8IVS8-4]
DR   AlphaFoldDB; Q8IVS8; -.
DR   SMR; Q8IVS8; -.
DR   BioGRID; 126307; 61.
DR   FunCoup; Q8IVS8; 804.
DR   IntAct; Q8IVS8; 59.
DR   MINT; Q8IVS8; -.
DR   STRING; 9606.ENSP00000389175; -.
DR   GlyGen; Q8IVS8; 1 site.
DR   iPTMnet; Q8IVS8; -.
DR   PhosphoSitePlus; Q8IVS8; -.
DR   BioMuta; GLYCTK; -.
DR   DMDM; 74728080; -.
DR   jPOST; Q8IVS8; -.
DR   MassIVE; Q8IVS8; -.
DR   PaxDb; 9606-ENSP00000389175; -.
DR   PeptideAtlas; Q8IVS8; -.
DR   ProteomicsDB; 70758; -. [Q8IVS8-1]
DR   ProteomicsDB; 70759; -. [Q8IVS8-2]
DR   ProteomicsDB; 70760; -. [Q8IVS8-3]
DR   ProteomicsDB; 70761; -. [Q8IVS8-4]
DR   ProteomicsDB; 70762; -. [Q8IVS8-5]
DR   ProteomicsDB; 70763; -. [Q8IVS8-6]
DR   ProteomicsDB; 70764; -. [Q8IVS8-7]
DR   Antibodypedia; 1847; 270 antibodies from 30 providers.
DR   DNASU; 132158; -.
DR   Ensembl; ENST00000305690.12; ENSP00000301965.9; ENSG00000168237.18. [Q8IVS8-2]
DR   Ensembl; ENST00000436784.7; ENSP00000389175.2; ENSG00000168237.18. [Q8IVS8-1]
DR   Ensembl; ENST00000473032.5; ENSP00000418951.1; ENSG00000168237.18. [Q8IVS8-7]
DR   Ensembl; ENST00000477382.1; ENSP00000419008.1; ENSG00000168237.18. [Q8IVS8-2]
DR   GeneID; 132158; -.
DR   KEGG; hsa:132158; -.
DR   MANE-Select; ENST00000436784.7; ENSP00000389175.2; NM_145262.4; NP_660305.2.
DR   UCSC; uc003ddo.4; human. [Q8IVS8-1]
DR   AGR; HGNC:24247; -.
DR   CTD; 132158; -.
DR   DisGeNET; 132158; -.
DR   GeneCards; GLYCTK; -.
DR   HGNC; HGNC:24247; GLYCTK.
DR   HPA; ENSG00000168237; Tissue enriched (liver).
DR   MalaCards; GLYCTK; -.
DR   MIM; 220120; phenotype.
DR   MIM; 610516; gene.
DR   OpenTargets; ENSG00000168237; -.
DR   Orphanet; 941; D-glyceric aciduria.
DR   VEuPathDB; HostDB:ENSG00000168237; -.
DR   eggNOG; KOG3935; Eukaryota.
DR   GeneTree; ENSGT00390000014365; -.
DR   HOGENOM; CLU_112512_0_0_1; -.
DR   InParanoid; Q8IVS8; -.
DR   OMA; GKAAWRM; -.
DR   OrthoDB; 44918at2759; -.
DR   PAN-GO; Q8IVS8; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q8IVS8; -.
DR   BRENDA; 2.7.1.31; 2681.
DR   PathwayCommons; Q8IVS8; -.
DR   Reactome; R-HSA-70350; Fructose catabolism.
DR   SABIO-RK; Q8IVS8; -.
DR   SignaLink; Q8IVS8; -.
DR   BioGRID-ORCS; 132158; 14 hits in 1158 CRISPR screens.
DR   ChiTaRS; GLYCTK; human.
DR   GenomeRNAi; 132158; -.
DR   Pharos; Q8IVS8; Tbio.
DR   PRO; PR:Q8IVS8; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8IVS8; protein.
DR   Bgee; ENSG00000168237; Expressed in right lobe of liver and 110 other cell types or tissues.
DR   ExpressionAtlas; Q8IVS8; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; HTP:FlyBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008887; F:glycerate kinase activity; IDA:UniProtKB.
DR   GO; GO:0061624; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; TAS:Reactome.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   FunFam; 3.40.50.10180:FF:000003; GLYCTK isoform 4; 1.
DR   Gene3D; 3.40.50.10180; Glycerate kinase, MOFRL-like N-terminal domain; 1.
DR   Gene3D; 3.40.1480.10; MOFRL domain; 1.
DR   InterPro; IPR037035; GK-like_C_sf.
DR   InterPro; IPR038614; GK_N_sf.
DR   InterPro; IPR007835; MOFRL.
DR   InterPro; IPR025286; MOFRL_assoc_dom.
DR   InterPro; IPR039760; MOFRL_protein.
DR   PANTHER; PTHR12227; GLYCERATE KINASE; 1.
DR   PANTHER; PTHR12227:SF0; GLYCERATE KINASE; 1.
DR   Pfam; PF13660; DUF4147; 1.
DR   Pfam; PF05161; MOFRL; 1.
DR   SUPFAM; SSF82544; GckA/TtuD-like; 1.
DR   neXtProt; NX_Q8IVS8; -.
DR   PharmGKB; PA162389865; -.
DR   TreeFam; TF313770; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Disease variant; Kinase;
KW   Mitochondrion; Nucleotide-binding; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Transferase.
FT   CHAIN           1..523
FT                   /note="Glycerate kinase"
FT                   /id="PRO_0000287192"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..336
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15498874, ECO:0000303|Ref.5"
FT                   /id="VSP_025356"
FT   VAR_SEQ         1..127
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025357"
FT   VAR_SEQ         119..184
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_025358"
FT   VAR_SEQ         178..205
FT                   /note="GGSALLPAPIPPVTLEEKQTLTRLLAAR -> WGTPAAHRDDRYQCHGHPPL
FT                   VPAASVMA (in isoform 7)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_025359"
FT   VAR_SEQ         179..234
FT                   /note="GSALLPAPIPPVTLEEKQTLTRLLAARGATIQELNTIRKALSQLKGGGLAQA
FT                   AYPA -> EPHPVRCGGGPCGGDCQWPHRGQFPQCARLPAYPQSLRPPCSPATFCEDCA
FT                   VSGRL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16753811"
FT                   /id="VSP_025360"
FT   VAR_SEQ         206..523
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_025361"
FT   VAR_SEQ         235..523
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16753811"
FT                   /id="VSP_025362"
FT   VAR_SEQ         340..367
FT                   /note="DVKSMAQFYGLLAHVARTRLTPSMAGAS -> WGTPAAHRDDRYQCHGHPPL
FT                   VPAASVMA (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_025363"
FT   VAR_SEQ         340..367
FT                   /note="DVKSMAQFYGLLAHVARTRLTPSMAGAS -> WGTPAAHRDDRYQCHGHPPI
FT                   VPAASVMA (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025364"
FT   VAR_SEQ         368..523
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.5"
FT                   /id="VSP_025365"
FT   VARIANT         27
FT                   /note="R -> C (in dbSNP:rs34502608)"
FT                   /id="VAR_061205"
FT   VARIANT         170
FT                   /note="L -> V (in dbSNP:rs35130772)"
FT                   /id="VAR_032285"
FT   VARIANT         394
FT                   /note="T -> I (in dbSNP:rs9813489)"
FT                   /id="VAR_032286"
FT   VARIANT         493
FT                   /note="F -> C (in D-GA; the mutant protein is not expressed
FT                   and has no enzymatic activity; dbSNP:rs121909448)"
FT                   /evidence="ECO:0000269|PubMed:20949620"
FT                   /id="VAR_065909"
FT   CONFLICT        144
FT                   /note="D -> Y (in Ref. 1; AAP51132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        245
FT                   /note="V -> E (in Ref. 4; BAB85018)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   523 AA;  55253 MW;  CCBEC88E8850FC11 CRC64;
     MAAALQVLPR LARAPLHPLL WRGSVARLAS SMALAEQARQ LFESAVGAVL PGPMLHRALS
     LDPGGRQLKV RDRNFQLRQN LYLVGFGKAV LGMAAAAEEL LGQHLVQGVI SVPKGIRAAM
     ERAGKQEMLL KPHSRVQVFE GAEDNLPDRD ALRAALAIQQ LAEGLTADDL LLVLISGGGS
     ALLPAPIPPV TLEEKQTLTR LLAARGATIQ ELNTIRKALS QLKGGGLAQA AYPAQVVSLI
     LSDVVGDPVE VIASGPTVAS SHNVQDCLHI LNRYGLRAAL PRSVKTVLSR ADSDPHGPHT
     CGHVLNVIIG SNVLALAEAQ RQAEALGYQA VVLSAAMQGD VKSMAQFYGL LAHVARTRLT
     PSMAGASVEE DAQLHELAAE LQIPDLQLEE ALETMAWGRG PVCLLAGGEP TVQLQGSGRG
     GRNQELALRV GAELRRWPLG PIDVLFLSGG TDGQDGPTEA AGAWVTPELA SQAAAEGLDI
     ATFLAHNDSH TFFCCLQGGA HLLHTGMTGT NVMDTHLLFL RPR
//
